Gibbs PH - Search Results

1

Long-term health effects of repeated exposure to multiple vaccines.

Pittman PR, Coonan KM, Gibbs PH, Scott HM, Cannon TL, McKee KT Jr. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 2004 Dec 9;23(4):525-36. doi: 10.1016/j.vaccine.2004.06.026. Vaccine. 2004. PMID: 15530702

2

Immune interference after sequential alphavirus vaccine vaccinations.

Pittman PR, Liu CT, Cannon TL, Mangiafico JA, Gibbs PH. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 2009 Aug 6;27(36):4879-82. doi: 10.1016/j.vaccine.2009.02.090. Epub 2009 Mar 11. Vaccine. 2009. PMID: 19576665

3

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans.

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little S, Pace-Templeton JG, Myers R, Parker GW, Friedlander AM. Pittman PR, et al. Vaccine. 2002 Jan 31;20(9-10):1412-20. doi: 10.1016/s0264-410x(01)00462-5. Vaccine. 2002. PMID: 11818160 Clinical Trial.

4

Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT Jr, Friedlander AM, Sjogren MH. Pittman PR, et al. Vaccine. 2002 May 15;20(16):2107-15. doi: 10.1016/s0264-410x(02)00058-0. Vaccine. 2002. PMID: 11972980

5

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

Rusnak JM, Gibbs P, Boudreau E, Clizbe DP, Pittman P. Rusnak JM, et al. Vaccine. 2011 Apr 12;29(17):3222-9. doi: 10.1016/j.vaccine.2011.02.037. Epub 2011 Feb 26. Vaccine. 2011. PMID: 21354483

6

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.

Pittman PR, Makuch RS, Mangiafico JA, Cannon TL, Gibbs PH, Peters CJ. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 1996 Mar;14(4):337-43. doi: 10.1016/0264-410x(95)00168-z. Vaccine. 1996. PMID: 8744562 Clinical Trial.

7

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 1999 Aug 20;18(1-2):181-9. doi: 10.1016/s0264-410x(99)00218-2. Vaccine. 1999. PMID: 10501248

8

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans.

Pittman PR, Mangiafico JA, Rossi CA, Cannon TL, Gibbs PH, Parker GW, Friedlander AM. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 2000 Sep 15;19(2-3):213-6. doi: 10.1016/s0264-410x(00)00174-2. Vaccine. 2000. PMID: 10930675

9

Anthrax vaccine: short-term safety experience in humans.

Pittman PR, Gibbs PH, Cannon TL, Friedlander AM. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 2001 Dec 12;20(5-6):972-8. doi: 10.1016/s0264-410x(01)00387-5. Vaccine. 2001. PMID: 11738765

10

US Military contributions to the global response to pandemic chikungunya.

Hoke CH Jr, Pace-Templeton J, Pittman P, Malinoski FJ, Gibbs P, Ulderich T, Mathers M, Fogtman B, Glass P, Vaughn DW. Hoke CH Jr, et al. Vaccine. 2012 Oct 19;30(47):6713-20. doi: 10.1016/j.vaccine.2012.08.025. Epub 2012 Aug 29. Vaccine. 2012. PMID: 22940380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters